Myrobalan Therapeutics
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $24M
Investors
- 3
About Myrobalan Therapeutics
a. Myrobalan Therapeutics operates as a developer of oral neurorestorative therapies aimed at reversing key pathologies underlying brain dysfunctions and CNS conditions. In January 2024, Myrobalan Therapeutics, Inc., and Program 4.
Who invested in Myrobalan Therapeutics
3 investors across 1 round
See all investors in Myrobalan Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 10, 2024
Amount
$24M
Investors
Questions about Myrobalan Therapeutics
Who invested in Myrobalan Therapeutics?
Myrobalan Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myrobalan Therapeutics raised?
Myrobalan Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Myrobalan Therapeutics last raise money?
Myrobalan Therapeutics's most recent round on record is a Series A, in Jan 2024.
What does Myrobalan Therapeutics do?
Myrobalan Therapeutics is a biotechnology company.
Where is Myrobalan Therapeutics headquartered?
Myrobalan Therapeutics is headquartered in US.
Which VCs invest in companies like Myrobalan Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Myrobalan Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Myrobalan Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.